New Key Statistics Module, Z-Score and F-Score
NAS:CTMX Key Ratios
| Market Cap $ M | 88.04 |
| Enterprise Value $ M | -17.38 |
| P/E(ttm) | 6.62 |
| PE Ratio without NRI | 6.62 |
| Forward PE Ratio | 11.82 |
| Price/Book | -- |
| Price/Sales | 0.75 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 126.00 |
| EPS (TTM) $ | 0.17 |
| Beneish M-Score | 1.47 |
| 10-y EBITDA Growth Rate % | 7.40 |
| 5-y EBITDA Growth Rate % | 42.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.59 |
| EV-to-EBITDA | -2.03 |
| PEG | 0.16 |
| Shares Outstanding M | 78.26 |
| Net Margin (%) | 10.92 |
| Operating Margin % | 5.30 |
| Pre-tax Margin (%) | 11.89 |
| Quick Ratio | 1.04 |
| Current Ratio | 1.04 |
| ROA % (ttm) | 7.63 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | 4.33 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.52 |
CTMX Number of Guru Trades
CTMX Volume of Guru Trades
Gurus Latest Trades with NAS:CTMX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTMX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CytomX Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CTMX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers